Jefferies Financial Group Upgrades ICU Medical (NASDAQ:ICUI) to Strong-Buy

Key Points

• Jefferies upgraded ICU Medical (NASDAQ:ICUI) to a "strong-buy" rating; analyst coverage is mixed (two Strong Buy, two Buy, one Sell) with a consensus price target of $169.
• ICU reported quarterly EPS of $1.91, beating estimates of $1.68, but revenue fell 14.1% year-over-year; the company set FY2026 guidance of 7.75–8.45 EPS versus analysts' average forecast of 6.31.
• Institutional investors own about 96.1% of the stock and several large funds raised positions; shares opened at $123 with a 12-month range of $107–$160.29 and a market cap of $3.08 billion.

ICU Medical (NASDAQ:ICUI - Get Free Report) was upgraded by equities researchers at Jefferies Financial Group to a "strong-buy" rating in a research note issued on Thursday,Zacks.com reports.

ICUI has been the topic of a number of other research reports. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of ICU Medical in a research note on Thursday, January 22nd. Piper Sandler cut their price target on shares of ICU Medical from $178.00 to $163.00 and set an "overweight" rating on the stock in a research note on Friday, April 17th. KeyCorp cut their price target on shares of ICU Medical from $180.00 to $164.00 and set an "overweight" rating on the stock in a research note on Monday, April 27th. Finally, Wall Street Zen lowered shares of ICU Medical from a "buy" rating to a "hold" rating in a research note on Saturday, April 18th. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, ICU Medical currently has an average rating of "Buy" and a consensus price target of $169.00.

ICU Medical Stock Performance

Shares of ICUI opened at $123.07 on Thursday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.15 and a current ratio of 2.39. ICU Medical has a twelve month low of $107.00 and a twelve month high of $160.29. The firm's 50 day moving average price is $128.93 and its two-hundred day moving average price is $138.35. The firm has a market cap of $3.08 billion, a P/E ratio of 6,156.58, a PEG ratio of 1.72 and a beta of 0.74.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its quarterly earnings results on Thursday, February 19th. The medical instruments supplier reported $1.91 earnings per share for the quarter, beating analysts' consensus estimates of $1.68 by $0.23. ICU Medical had a net margin of 0.03% and a return on equity of 7.33%. The firm had revenue of $535.94 million for the quarter, compared to analyst estimates of $541.20 million. During the same quarter in the previous year, the firm posted $2.11 earnings per share. The business's revenue was down 14.1% on a year-over-year basis. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, analysts forecast that ICU Medical will post 6.31 EPS for the current fiscal year.

Institutional Trading of ICU Medical

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its holdings in shares of ICU Medical by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 2,714,746 shares of the medical instruments supplier's stock valued at $387,313,000 after purchasing an additional 89,755 shares during the last quarter. Janus Henderson Group PLC increased its holdings in ICU Medical by 4.2% during the fourth quarter. Janus Henderson Group PLC now owns 2,576,756 shares of the medical instruments supplier's stock worth $367,625,000 after buying an additional 103,220 shares during the last quarter. Millennium Management LLC increased its holdings in ICU Medical by 173.4% during the third quarter. Millennium Management LLC now owns 1,089,017 shares of the medical instruments supplier's stock worth $130,638,000 after buying an additional 690,694 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in ICU Medical by 6.8% during the first quarter. Dimensional Fund Advisors LP now owns 983,802 shares of the medical instruments supplier's stock worth $127,053,000 after buying an additional 63,026 shares during the last quarter. Finally, State Street Corp increased its holdings in ICU Medical by 2.8% during the fourth quarter. State Street Corp now owns 942,670 shares of the medical instruments supplier's stock worth $134,491,000 after buying an additional 25,545 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.